Skip to main content
OpenTrials

Clinical trial condition

HCMV Reactivation or HCMV End-Organ Disease

Explore clinical trials studying HCMV Reactivation or HCMV End-Organ Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

HCMV Reactivation or HCMV End-Organ Disease trial results

Completed

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

NCT01063829

Conditions
HCMV Reactivation or HCMV End-Organ Disease
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Hospital Stanford, California, United States
  • Denver St. Lukes Presbyterian Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 24 locations
View Trial Details